Genetically modified T cells for the treatment of malignant disease - Wikidata - awgldk - TriplyDB

Genetically modified T cells for the treatment of malignant disease

Genetically modified T cells for the treatment of malignant disease

http://www.wikidata.org/entity/Q26860657

about

Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications Cytokine-induced killer (CIK) cells: from basic research to clinical translation.Chimeric Antigen Receptor T Cell Therapy in Hematology.IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.Advanced therapy medicinal products - a multiple challenge.Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.Next generation drug delivery: circulatory cells-mediated nanotherapeutic approaches.Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanoma.

P2860

Q26779221-4541B67C-B34F-4692-A86D-8C5D99FB0C93 Q36121153-6162452A-1307-4331-A373-438AB2F95BEF Q36722700-C06B1C76-7FCF-4F62-8E24-2C01FF58297F Q36727794-8C2B6B56-B3A8-44A4-997E-38D2FCAB4A7E Q37417622-EBA7E1B0-3049-454C-BB7A-EBF692FCB1EC Q38631020-7D42AC31-C2DE-4388-AB4F-E51BF2D2E00B Q41890519-DC345D07-848A-49A5-987B-7A3E860B54B8 Q50035982-9535A713-8510-4678-83DD-5890F4CCD955 Q52840157-B6252E53-9A8C-4F7C-9A4C-DE1069876730 Q52859139-FC3025FD-668C-44DC-87A1-810452FA6ED6

P2860

Genetically modified T cells for the treatment of malignant disease

http://www.wikidata.org/entity/Q26860657

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Genetically modified T cells for the treatment of malignant disease

@ast

Genetically modified T cells for the treatment of malignant disease

@en

Genetically modified T cells for the treatment of malignant disease

@nl

type

label

Genetically modified T cells for the treatment of malignant disease

@ast

Genetically modified T cells for the treatment of malignant disease

@en

Genetically modified T cells for the treatment of malignant disease

@nl

prefLabel

Genetically modified T cells for the treatment of malignant disease

@ast

Genetically modified T cells for the treatment of malignant disease

@en

Genetically modified T cells for the treatment of malignant disease

@nl

P1433

Q26860657-5675441F-C9C0-4C41-B8BF-4E5566449C5B

P1476

Q26860657-39CFD82A-7ACB-4879-8CBD-379AE08363E5

P2093

Q26860657-20F23B2D-02C0-416C-A5E1-9CD6B7A70723

Q26860657-468C01CD-36B5-4645-B480-92E00CA2019D

P2860

Q26860657-05B09E82-A10D-4927-A909-CE80FC43A8C8

Q26860657-05E1210C-4F6A-44B9-B81D-B09E9962D43B

Q26860657-068824DD-57BB-4F41-87A9-EBBD135B9F98

Q26860657-079E99C4-FE9E-489B-8072-32E6AF484335

Q26860657-17B7BD48-C74A-4EAE-89DC-25B1CE013DC0

Q26860657-183E484E-E56C-4F42-B07F-2C0DBACE6E1E

Q26860657-1914880A-BF6D-43F0-81F9-93075D0C3671

Q26860657-1A9CE307-F625-4AD4-853D-10C5357A7E58

Q26860657-1CDDF255-2B8E-4CA9-A519-8187EC9509D2

Q26860657-20DA1468-08AF-45FA-AAED-DFCDAD7F4E4F

P304

Q26860657-6B79F411-8106-4662-B7DC-EAA1115B35A2

P31

Q26860657-65F99B7A-D544-4B7A-B430-76EC36C0C80D

P356

Q26860657-627AF337-C4C9-4CD4-885B-CB27373B2454

P407

Q26860657-33AF4ABF-8F81-4C0B-8037-91261D4C40E3

P433

Q26860657-0A6B280D-0C68-4CD5-93F2-FDB6883A921D

P478

Q26860657-B5FD0F93-6E33-4529-A0E4-18551DAD6731

P577

Q26860657-8B85814F-D6F0-4B3E-BCFE-691B100926DE

P5875

Q26860657-0D54E483-D6C7-46A5-A7D9-42DFCA3E1F26

P698

Q26860657-CD33AC0F-DF79-4E9D-8DBF-FF09A56150F3

P932

Q26860657-D219B65E-4EB6-4DEF-A90D-D0CDF3214B9D

P356

P1433

Transfusion Medicine and Hemotherapy

P1476

Genetically modified T cells for the treatment of malignant disease

@en

P2093

Agnieszka Wieczorek

http://www.w3.org/2001/XMLSchema#string

Lutz Uharek

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Cancer regression in patients after transfer of genetically engineered lymphocytes

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

A human memory T cell subset with stem cell-like properties

(Re)defining biopharmaceutical

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

P304

388-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000357163

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259961174

http://www.w3.org/2001/XMLSchema#string

P698

24474888

http://www.w3.org/2001/XMLSchema#string

P932

3901623

http://www.w3.org/2001/XMLSchema#string